CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Raffaele Capasso - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Raffaele Capasso

OPENALEX: A5059461366↗ORCID: 0000-0002-3335-1822↗

Affiliations

Organizations

Department of Agricultural Sciencesauthorship · RU Federico II University Hospitalauthorship · IT National Research Councilauthorship · IT University of Naples Federico IIauthorship · IT

Public evidence

6 connected articles

Dysfunctional endocannabinoid CB1 receptor expression and signaling contribute to skeletal muscle cell toxicity induced by simvastatin.2023 · Europe PMC Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?2020 · Europe PMC Role of 2-Arachidonoyl-Glycerol and CB1 Receptors in Orexin-A-Mediated Prevention of Oxygen-Glucose Deprivation-Induced Neuronal Injury.2020 · Europe PMC Antidepressant-Like Effect of Terpineol in an Inflammatory Model of Depression: Involvement of the Cannabinoid System and D2 Dopamine Receptor.2020 · Europe PMC Terpenoids, Cannabimimetic Ligands, beyond the <i>Cannabis</i> Plant.2020 · Europe PMC An Orally Active <i>Cannabis</i> Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse.2016 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.